RedHill Biopharma(RDHL)
$0.350.00 (0.00%)
RDHL
RedHill Biopharma earnings date
$0.35
At close:0.00 (0.00%)
Want to see RDHL full AI Analyst Report?
RedHill Biopharma (RDHL) Q2 2021 Earnings Report
904 Followers
RDHL Q2 2021 EPS Results
- Actual EPS
- -$600.00
- Consensus EPS
- -$352.86
- Beat/Miss
- Missed by -$247.14
- One Year Ago EPS
- -$400.00
RDHL Q2 2021 Revenue Results
- Actual Revenue
- $21.58M
- Expected Revenue
- $24.29M
- Beat/Miss
- Missed by -$2.70M
- YoY Revenue Growth
- +2.31%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/26/2021
- Time
- Before Open
- Conference Call
- Thursday, August 26, 2021
RDHL Upcoming Earnings
RedHill Biopharma's next earnings date is estimated for March 18, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
RDHL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 18, 2027 | 2026 (Q4) | ―- | ― | ― | ― |
| Sep 30, 2026 | 2026 (Q2) | ―-1.01 | -2.32 | 56.56% (+1.31) | |
| Apr 27, 2026 | 2025 (Q4) | ―- | ― | ― | |
| Sep 05, 2025 | 2025 (Q2) | ―-2.32 | 0 | ― | |
| May 13, 2025 | 2025 (Q1) | ―- | ― | ― | |
| Apr 10, 2025 | 2024 (Q4) | ―- | ― | ― | |
| Aug 29, 2024 | 2024 (Q2) | ―0.00 | 1 | -100.00% (-1.00) | |
| May 07, 2024 | 2024 (Q1) | ―- | ― | ― | |
| Apr 08, 2024 | 2023 (Q4) | ―- | -0.05 | ― | |
| Nov 15, 2023 | 2023 (Q3) | ―0.04 | -2.4 | 101.67% (+2.44) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

